An Open-Label, Multicentre, Long-term Extension Study of Tislelizumab-Containing Treatment and/or Pamiparib-Containing Treatment in Patients With Advanced Malignancies

  • Frentzas, Sophia (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date28/11/19 → 27/11/24

Keywords

  • clinical trial
  • treatment efficacy
  • treatment safety
  • malignancy

Clinical Trial Phase

  • Phase III (a & b)